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Abstract
The impaired ability of the elderly to mount an efficient immune re-
sponse after exposure to microbes or vaccines represents a major chal-
lenge in protection against pathogens in ageing. Recently studies have 
shown that stimulation of Toll-like receptors (TLRs), using stimulatory 
ligands, can enhance vaccine efficacy by a number of mechanisms, 
including the activation of innate immune cells and the consequent 
production of inflammatory cytokines. Since TLR stimulation is a key 
regulator of the type and magnitude of the immune response, we eva-
luated cytokine production in dendritic cell populations upon stimula-
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tion with two complementary TLR agonists, R848 and MPLA. Our pre-
liminary results demonstrate that TLR activation by this combination 
of agonists can signiﬁcantly enhance the activation of dendritic cells in 
the peripheral blood isolated from healthy elderly donors. This data 
suggest that the inclusion of appropriate combination of TLR agonists 
may enhance the efficacy of vaccination in the elderly.
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Introduction
Increasing age is accompanied by a progressive decline of both the 
innate and acquired immune system, noted as “Immunosenescence” 
[Caruso & Vasto, 2016].
The impact of ageing on the immune system typically includes 
intrinsic defects within immune cells as well as alterations in number 
and activity, and possibly defects in the bone marrow and thymic 
stromal microenvironment. This phenomenon results in a reduction 
of naive T and B cells, leading to inefficient primary responses of im-
mune effector cells to pathogens, as well as reduced T cell cytotoxi-
city, proliferation and cytokine production, and defective memory 
responses in the elderly population [Larbi et al., 2008; Caruso et al., 
2009; Nikolich-Zugich & Rudd, 2010]. Consequently, aged indivi-
duals exhibit increased incidence of infectious diseases, cancer and 
autoimmune diseases [McElhaney et al., 2012]. In addition, their aged 
immune system does not respond to stimuli as efficiently as that of 
younger adults, therefore current vaccines are less effective in the el-
derly [Derhovanessian & Pawelec, 2012]. 
Research in immunological ageing seeks not only to understand 
the age-related disorders of immune regulation, but also to identify 
new efficient strategies for immune rejuvenation and for effective vac-
cination induced immunity in the elderly. One such strategy would 
be to develop vaccines comprising suitable adjuvants to enhance the 
impaired cellular immune responses [Wells et al., 2008]. 
Adjuvants are molecules that stimulate the non-speciﬁc, innate 
immune responses, inducing the activation of antigen presenting 
cells (APCs) and their recruitment to the site of vaccination. Dendri-
tic cells (DCs) are the most potent APCs, specialized in the uptake, 
processing, transport and presentation of antigens to T cells [Collin 
et al., 2013]. After their activation in the periphery, DCs migrate to 
lymphoid tissues where they interact with T and B cells to initiate and 
shape the acquired immune responses. 
DCs in human blood are deﬁned as Lineage 1 (CD3, CD14, CD16, 
CD19, CD20, and CD56)-negative and HLA-DR-positive cells. DCs can be 
divided into three subsets according to the expression of various markers 
(CD123, CD1c, CD141): one subset of plasmacytoid DCs (pDCs), and two 
subsets of myeloid DCs (mDCs). pDCs are characterized by the expression 
of CD123 marker and possess the capacity to produce high levels of type I 
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Interferons (IFN-α/β). In contrast, mDCs express the CD11c marker and 
are divided into two subsets: CD1c+ mDCs and CD141+ mDCs [Collin et 
al., 2013]. Upon stimulation, mDCs secrete mainly IL-6, IL-12, and TNF-α. 
Both pDCs and mDCs express toll-like receptors (TLRs) that recogni-
ze conserved molecular patterns on microbes and are key regulators of 
antimicrobial host defence responses. Recognition of microbial compo-
nents by TLRs culminates in the secretion of type I IFNs and pro-inflam-
matory cytokines that facilitate the linkage of innate to acquired immune 
responses. Deﬁciencies in human TLR signalling lead to increased seve-
rity of multiple immunological disorders, including sepsis, immunode-
ﬁciencies, atherosclerosis and asthma [Cook et al., 2004]. 
Recently, stimulation of TLRs by adjuvants has been shown to be a pro-
mising strategy to enhance vaccine efficacy against both foreign and self, 
tumour-associated, antigens in aged mice by activating innate immune cells 
and enhancing production of inflammatory cytokines [Tye et al., 2015]. 
On the basis of these promising results in mice, we have investiga-
ted the ability of combined TLR ligands to induce pro-inflammatory 
responses in the peripheral blood dendritic cells isolated from heal-
thy donors with evidence of immunosenescence.
Material and Methods 
Samples
A total of 23 samples, including ﬁve centenarians, ﬁve centenarian off-
spring (CO), six old donors and six young donors used as controls, were 
processed. All participants were in good health according to their clinical 
history and none of them had infectious, inflammatory, neoplastic or au-
toimmune diseases at the time of the study. The University Hospital Ethics 
Committee approved the study, and written informed consent was obtained 
from all participants according to Italian law. Whole blood was collected by 
venepuncture in vacutainer tubes containing ethylenediaminetetraacetic 
acid. Peripheral blood mononuclear cells (PBMCs) were isolated by den-
sity gradient centrifugation on Lympholyte® (Cedarlane, Canada, United 
States) and viably cryopreserved according to standard protocols.
DCs stimulation assay
Total PBMCs were cultured at 1x106 cells/well on a 96 U-bottom 
plate. Cells were plated with a combination of two adjuvants, chosen 
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based on our preliminary experiments, in the presence of 1x Golgi 
Plug solution (BD Biosciences, Erembodegem, Belgium). Speciﬁcally, 
we tested the following TLR agonists: the TLR7/8 agonist R848, at 3 
μg/ml, and the TLR4 agonist MPLA, at 10 μg/ml (InvivoGen, San Di-
ego, California). For each donor, cells were also left unstimulated and 
served as controls. After 6 hours of incubation cells were transferred 
to labelled FACS tubes and stained with antibodies. We chose to study 
total PBMCs, rather than puriﬁed DCs, to minimize manipulations that 
might result in partial activation of DCs, and because puriﬁcation pro-
cedures would substantially decrease the yield of cells for analysis.
Flow cytometry and cell sorting 
Cells were stained with antibodies to human CD3, CD14, CD16, CD19, 
CD20, CD56 (Lineage 1, BD Biosciences, Erembodegem, Belgium), HLA-
DR (clone L243, Biolegend, San Diego, California), CD123 (clone 6H6, Bio-
legend), CD1c (clone L161, Biolegend), CD11c (clone 3.9,Biolegend), and 
CD141 (clone 1A4, BD Biosciences) for extracellular staining. For intracel-
lular staining, cells were then washed, ﬁxed with permeabilization/ﬁxa-
tion buffer (BD Biosciences) and stained with antibodies to human IL-6 
(clone MQ2-13A5, Biolegend), TNF-α (clone Mab11, Biolegend), and the 
p40 subunit of IL-12/23 (clone C11.5, Biolegend). Samples were analysed 
by flow cytometry on a LSR Fortessa™  (BD Biosciences). FACS data were 
analysed and plotted using FlowJo software (Tree Star). 
Statistics  
Statistical analyses were performed using GraphPad Prism 
software; the signiﬁcant level of p value was determined using Stu-
dent t test. (* p < 0.05, ** p ≤ 0.01, *** p ≤ 0.001) 
Results and Discussion
Given that DC activation is a key regulator of the magnitude and 
nature of the elicited adaptive immune responses, we evaluated 
whether TLR ligands could effectively activate naturally occurring, 
circulating DCs. To this end, we stimulated total PBMCs, derived 
from young, aged, centenarian and CO participants, with a combi-
nation of two TLR ligands. The nature and magnitude of cytokine 
production was assessed using multi-parameter flow cytometry. 
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Our preliminary in vitro screening experiments suggest that from 
the various TLR agonists tested, the condition that most effectively 
activated human leukocytes was the combination of TLR7/TLR8 with 
TLR4. This TLR agonist combination induces signiﬁcantly greater 
cytokine production than that induced by each of the individual ago-
nist. This greater stimulation is probably due to the combined activa-
tion of both Myd88 and TRIF-dependent signal transduction pathways. 
Figure 1 shows an example of our analysis; after excluding dou-
blets, we gated the Lineage (consisting of a cocktail of antibodies 
against CD3, CD14, CD16, CD19, and CD56)-negative, HLA-DR-po-
sitive population, with mDCs and pDCs identiﬁed as CD11c and 
CD123 positive cells, respectively. Subsequently, using intracellular 
cytokine staining, we evaluated the selected populations for the pro-
duction of TNF-α, IL-6 and IL-12p40.
Figure 1. Characterization of human dendritic cells and their subsets. 
Phenotype of human DCs analysed by flow cytometry. Cells were gated on 
Lineage-1 negative HLA-DR-positive population by a cocktail of antibodies 
against CD3, CD14, CD16, CD19, and CD56. Subsequently, mDCs and pDCs 
were identiﬁed using staining against CD11, CD123, CD1c and CD141.
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First, we report that the stimulation of cells with the combination 
of agonists for TLR7/8 and TLR4 is de facto an excellent inducer of 
TNF-α and IL-12/p40 cytokines in the CD141+ mDCs from young, 
old and CO subjects, with signiﬁcantly high levels of cytokines com-
pared to unstimulated samples (p < 0.05,  p ≤ 0.01, and  p ≤ 0.001; re-
spectively). No signiﬁcant variation was observed in centenarians 
(Figure 2A). This, probably, is due to the age-related lower viabili-
ty and low number of centenarian samples. Nevertheless, we have 
reported that the difficulties to study centenarians can be overcome 
by studying CO that are one generation (about 20-30 years) younger 
than centenarians and are representative of an elderly cohort, cha-
racterised by a better functional status and a reduced risk for several 
age-related pathologies [Balistreri et al., 2014]. Focusing on old peo-
ple, we observed that both Italian CO and elderly, showed elevated 
percentage of IL-12/p40 and TNF-α after treatment with the TLR li-
gands R848 (TLR7/8) and MPLA (TLR4); these differences were hi-
ghly statistically signiﬁcant compared to unstimulated cells.
Notably, the combination of R848 and MPLA induce 5–10 fold higher 
production of IL-12/p40 in CD141+ mDCs isolated from old and CO 
samples compared with their young counterparts (p ≤ 0.01) (Figure 2A). 
In addition, increased amounts of TNF-α, were also observed in 
CD1c+ mDCs and pDCs from older and CO subjects, in response to 
R848 and MPLA stimulation. These differences were statistically signiﬁ-
cant when compared to their unstimulated counterparts (Figure 2B). 
Taken together, the data presented suggest that the combination of R848 
and MPLA effectively promotes in vitro cytokine production in human DCs 
isolated from elderly, despite their immunosenescent phenotype.
To date, data regarding the influence of ageing on human DCs 
activity and cytokine production, in response to in vitro stimulation, 
has been inconsistent, showing either comparable or reduced DC 
function in the elderly [Lung et al., 2000; Pietschmann et al., 2000; 
Shurin et al., 2007]. Tan et al., [2012] report that human DCs isolated 
from both young and aged individuals exhibit comparable activation 
in response to most TLR ligands, and are equally capable of direct 
and cross-presentation of antigens to T cells in vitro. On the con-
trary, You et al., [2013]demonstrated a reduced production of TNF-α 
by DCs from old people in response to LPS stimulation. 
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Figure 2. Cytokine secretion by DCs. (A) TNF-α and IL-12 secretion from 
CD141+ mDCs in response to TLR7/8 and TLR4 stimulation in vitro. PB-
MCs were cultured in the absence or presence of combined TLR7/8 and 
TLR4 ligands (unstimulated and adjuvants, respectively). After incubation, 
CD141+ mDCs were identiﬁed by flow cytometry analysis. TNF-α and 
IL-12 were evaluated using intracellular staining and analysed by FlowJo. 
The data report the percentage of cytokines produced from young, elder-
ly, CO and centenarian samples after incubation. Statistical signiﬁcance 
between the groups has been reported as *p, 0.05, **p, 0.01, ***p, 0.001. (B) 
TNF-α secretion from pDCs and CD1c+ mDCs in response to TLR7/8 and 
TLR4 stimulation in vitro. PBMCs were cultured in the absence or pres-
ence of combined TLR7/8 and TLR4 ligands (unstimulated and adjuvants, 
respectively). After incubation, pDCs and CD1c+ mDCs were identiﬁed 
by flow cytometry analysis. The data report the percentage of TNF-α pro-
duced from each sample group after incubation. Statistical signiﬁcance 
between the groups has been reported as *p, 0.05, **p, 0.01, ***p, 0.001.
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In our study, stimulation with the speciﬁc combination of TLR 
agonists, R848 and MPLA, induced signiﬁcantly higher cytokine se-
cretion by mDCs and pDCs from both elderly and CO subjects. This 
has potentially important implications, since it has been reported that 
reduced production of TNF-α by pDCs from old people, caused by 
defects in TLR signalling pathways, is associated with an ineffective 
antibody response to influenza vaccination [Panda et al., 2010]. 
The involvement of TNF-α in DC-induced T cell proliferation 
is also evident from clinical data of rheumatoid arthritis patients, 
showing that treatment with anti-TNF-α antibodies cause poor sti-
mulation of T cell activity by DCs [Baldwin et al., 2010; Liu et al., 
2012]. Thus, impaired production of TNF-α by older DCs could result 
in a weak response to vaccination and may contribute to the dysregu-
lation of DC-induced T cell proliferation in the elderly subjects. 
Conclusion
Our ﬁndings highlight the efficient effect of adjuvant in stimula-
tion of cytokine production, and point towards the potential use of 
appropriately selected combination of TLR agonists in future vacci-
nation approaches for the elderly.
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